Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units

View ORCID ProfileAndrew Conway-Morris, Katherine Sharrocks, View ORCID ProfileRachel Bousfield, Leanne Kermack, View ORCID ProfileMailis Maes, View ORCID ProfileEllen Higginson, View ORCID ProfileSally Forrest, Joana Pereira-Dias, View ORCID ProfileClaire Cormie, Tim Old, Sophie Brooks, View ORCID ProfileIslam Hamed, Alicia Koenig, Andrew Turner, Paul White, R. Andres Floto, View ORCID ProfileGordon Dougan, View ORCID ProfileEffrossyni Gkrania-Klotsas, View ORCID ProfileTheodore Gouliouris, View ORCID ProfileStephen Baker, View ORCID ProfileVilas Navapurkar
doi: https://doi.org/10.1101/2021.09.16.21263684
Andrew Conway-Morris
1The John Farman ICU, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
2University Division of Anaesthesia, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Conway-Morris
Katherine Sharrocks
3Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Bousfield
3Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
4Clinical Microbiology Laboratory, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rachel Bousfield
Leanne Kermack
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mailis Maes
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mailis Maes
Ellen Higginson
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ellen Higginson
Sally Forrest
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sally Forrest
Joana Pereira-Dias
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Cormie
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire Cormie
Tim Old
3Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Brooks
3Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Islam Hamed
1The John Farman ICU, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Islam Hamed
Alicia Koenig
1The John Farman ICU, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Turner
6Department of Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, Cambridge UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul White
6Department of Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, Cambridge UK
7Medical Technology Research Centre and School of Medicine, Anglia Ruskin University, Chelmsford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Andres Floto
8Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK
9Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Dougan
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gordon Dougan
Effrossyni Gkrania-Klotsas
3Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Effrossyni Gkrania-Klotsas
Theodore Gouliouris
3Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
4Clinical Microbiology Laboratory, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Theodore Gouliouris
Stephen Baker
5Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen Baker
Vilas Navapurkar
1The John Farman ICU, Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vilas Navapurkar
  • For correspondence: Vilas.navapurkar@addenbrookes.nhs.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Background The COVID-19 pandemic has overwhelmed the respiratory isolation capacity in hospitals; many wards lacking high-frequency air changes have been repurposed for managing patients infected with SARS-CoV-2 requiring either standard or intensive care. Hospital-acquired COVID-19 is a recognised problem amongst both patients and staff, with growing evidence for the relevance of airborne transmission. This study examined the effect of air filtration and ultra-violet (UV) light sterilisation on detectable airborne SARS-CoV-2 and other microbial bioaerosols.

Methods We conducted a crossover study of portable air filtration and sterilisation devices in a repurposed ‘surge’ COVID ward and ‘surge’ ICU. National Institute for Occupational Safety and Health (NIOSH) cyclonic aerosol samplers and PCR assays were used to detect the presence of airborne SARS-CoV-2 and other microbial bioaerosol with and without air/UV filtration.

Results Airborne SARS-CoV-2 was detected in the ward on all five days before activation of air/UV filtration, but on none of the five days when the air/UV filter was operational; SARS-CoV-2 was again detected on four out of five days when the filter was off. Airborne SARS-CoV-2 was infrequently detected in the ICU. Filtration significantly reduced the burden of other microbial bioaerosols in both the ward (48 pathogens detected before filtration, two after, p=0.05) and the ICU (45 pathogens detected before filtration, five after p=0.05).

Conclusions These data demonstrate the feasibility of removing SARS-CoV-2 from the air of repurposed ‘surge’ wards and suggest that air filtration devices may help reduce the risk of hospital-acquired SARS-CoV-2.

Funding Wellcome Trust, MRC, NIHR

Competing Interest Statement

Vilas Navapurkar is the founder, Director, and shareholder of Cambridge Infection Diagnostics Ltd. Andrew Conway-Morris, Paul White, Gordon Dougan and Stephen Baker are members of the Scientific Advisory Board of Cambridge Infection Diagnostics Ltd. Theodore Gouliouris has received a research grant from Shionogi. R Andres Floto has received research grants and/or consultancy payments from GSK, AZ, Chiesi, Shionogi, Insmed, Thirty Technology. Effrossyni Gkrania-Klotsas has received a National Institute of Health Research Greenshoots Award

Clinical Trial

Service evaluation of ability of a device to remove bioaerosol not involving patient data

Funding Statement

This work was supported by a Wellcome senior research fellowship to Stephen Baker (215515/Z/19/Z). Andrew Conway Morris is supported by a Clinician Scientist Fellowship from the Medical Research Council (MR/V006118/1). Mailis Maes and Sally Forrest are funded by the National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UK National Institute for Health Research confirmed that ethical approval was not required for this work.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing interests Vilas Navapurkar is the founder, Director, and shareholder of Cambridge Infection Diagnostics Ltd. Andrew Conway-Morris, Paul White, Gordon Dougan and Stephen Baker are members of the Scientific Advisory Board of Cambridge Infection Diagnostics Ltd. Theodore Gouliouris has received a research grant from Shionogi. R Andres Floto has received research grants and/or consultancy payments from GSK, AZ, Chiesi, Shionogi, Insmed, Thirty Technology. Effrossyni Gkrania-Klotsas has received a National Institute of Health Research Greenshoots Award

  • Funding This work was supported by a Wellcome senior research fellowship to Stephen Baker (215515/Z/19/Z). Andrew Conway Morris is supported by a Clinician Scientist Fellowship from the Medical Research Council (MR/V006118/1). Mailis Maes and Sally Forrest are funded by the National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

    The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

    The study was registered as a service evaluation with Cambridge University Hospitals NHS Foundation Trust (Service Evaluation Number PRN 9798).

Data Availability

Data is available on request to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units
Andrew Conway-Morris, Katherine Sharrocks, Rachel Bousfield, Leanne Kermack, Mailis Maes, Ellen Higginson, Sally Forrest, Joana Pereira-Dias, Claire Cormie, Tim Old, Sophie Brooks, Islam Hamed, Alicia Koenig, Andrew Turner, Paul White, R. Andres Floto, Gordon Dougan, Effrossyni Gkrania-Klotsas, Theodore Gouliouris, Stephen Baker, Vilas Navapurkar
medRxiv 2021.09.16.21263684; doi: https://doi.org/10.1101/2021.09.16.21263684
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units
Andrew Conway-Morris, Katherine Sharrocks, Rachel Bousfield, Leanne Kermack, Mailis Maes, Ellen Higginson, Sally Forrest, Joana Pereira-Dias, Claire Cormie, Tim Old, Sophie Brooks, Islam Hamed, Alicia Koenig, Andrew Turner, Paul White, R. Andres Floto, Gordon Dougan, Effrossyni Gkrania-Klotsas, Theodore Gouliouris, Stephen Baker, Vilas Navapurkar
medRxiv 2021.09.16.21263684; doi: https://doi.org/10.1101/2021.09.16.21263684

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1110)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (275)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (505)
  • Epidemiology (9796)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2327)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1567)
  • Health Policy (737)
  • Health Systems and Quality Improvement (608)
  • Hematology (238)
  • HIV/AIDS (508)
  • Infectious Diseases (except HIV/AIDS) (11669)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2154)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (519)
  • Oncology (1185)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (314)
  • Pediatrics (699)
  • Pharmacology and Therapeutics (303)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2195)
  • Public and Global Health (4685)
  • Radiology and Imaging (786)
  • Rehabilitation Medicine and Physical Therapy (458)
  • Respiratory Medicine (625)
  • Rheumatology (276)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (212)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)